{"id":"https://openalex.org/W2990399187","doi":"https://doi.org/10.1002/prp2.546","title":"Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy","display_name":"Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy","alternate_titles":[],"publication_year":2019,"publication_date":"2019-11-20","ids":{"openalex":"https://openalex.org/W2990399187","doi":"https://doi.org/10.1002/prp2.546","mag":"2990399187","pmid":"https://pubmed.ncbi.nlm.nih.gov/31763045","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6864408"},"language":"en","primary_location":{"id":"doi:10.1002/prp2.546","doi":"https://doi.org/10.1002/prp2.546","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.546","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.546","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2990399187"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.546","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063972597","display_name":"Lynn Miesel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lynn Miesel","raw_affiliation_strings":["Eurofins Panlabs Taipei Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eurofins Panlabs Taipei Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113886997","display_name":"Kun\u2010Yuan Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kun\u2010Yuan Lin","raw_affiliation_strings":["Eurofins Panlabs Taipei Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eurofins Panlabs Taipei Taiwan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090249918","display_name":"Voon S. Ong","orcid":"https://orcid.org/0000-0001-8676-6717","observed_orcids":["https://orcid.org/0000-0001-8676-6717"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Voon Ong","raw_affiliation_strings":["Cidara Therapeutics, Inc San Diego CA USA"],"raw_orcid":"https://orcid.org/0000-0001-8676-6717","affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, Inc San Diego CA USA","institution_ids":["https://openalex.org/I4210140218"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090249918"],"corresponding_institution_ids":["https://openalex.org/I4210140218"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":4.4798,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.95437637,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"7","issue":"6","first_page":"e00546","last_page":"e00546"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11900","display_name":"Fungal Plant Pathogen Control","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rezafungin","display_name":"rezafungin","score":0.8999999761581421},{"id":"https://openalex.org/keywords/echinocandins","display_name":"echinocandins","score":0.8790000081062317},{"id":"https://openalex.org/keywords/invasive-candidiasis","display_name":"invasive candidiasis","score":0.9679999947547913},{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antifungal-efficacy","display_name":"antifungal efficacy","score":0.7419999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics-pharmacodynamics","display_name":"pharmacokinetics/pharmacodynamics","score":0.8349999785423279},{"id":"https://openalex.org/keywords/neutropenic-mouse-model","display_name":"neutropenic mouse model","score":0.7770000100135803},{"id":"https://openalex.org/keywords/disseminated-fungal-infection","display_name":"disseminated fungal infection","score":0.7820000052452087},{"id":"https://openalex.org/keywords/intra-abdominal-abscess","display_name":"intra-abdominal abscess","score":0.8190000057220459},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2779320740","wikidata":"https://www.wikidata.org/wiki/Q3718510","display_name":"Echinocandin","level":4,"score":0.846406102180481},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7122532725334167},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.6366895437240601},{"id":"https://openalex.org/C2780917455","wikidata":"https://www.wikidata.org/wiki/Q310443","display_name":"Candida albicans","level":2,"score":0.6312747001647949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.619571328163147},{"id":"https://openalex.org/C2909919671","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal drugs","level":3,"score":0.5478205680847168},{"id":"https://openalex.org/C2780315139","wikidata":"https://www.wikidata.org/wiki/Q419639","display_name":"Azole","level":3,"score":0.48857173323631287},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4789046049118042},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44766873121261597},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4214118421077728},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4171483516693115},{"id":"https://openalex.org/C2991737395","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal drug","level":3,"score":0.4121086597442627},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.34463319182395935},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3311503827571869},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.258766233921051},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2322733998298645},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22920799255371094},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.213422954082489},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.20920100808143616},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D001232","descriptor_name":"Aspergillus fumigatus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001232","descriptor_name":"Aspergillus fumigatus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016867","descriptor_name":"Immunocompromised Host","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D058365","descriptor_name":"Candidiasis, Invasive","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D058365","descriptor_name":"Candidiasis, Invasive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058365","descriptor_name":"Candidiasis, Invasive","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D058365","descriptor_name":"Candidiasis, Invasive","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/prp2.546","doi":"https://doi.org/10.1002/prp2.546","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.546","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.546","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6864408","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6864408/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Res Perspect","raw_type":"Text"},{"id":"pmid:31763045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31763045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology research & perspectives","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:45ab665ee63e41fbac2adf1b76ea1d2b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/45ab665ee63e41fbac2adf1b76ea1d2b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology Research & Perspectives, Vol 7, Iss 6, Pp n/a-n/a (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/prp2.546","doi":"https://doi.org/10.1002/prp2.546","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.546","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.546","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312222","display_name":"Cidara Therapeutics","ror":"https://ror.org/044pnsw08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990399187.pdf","grobid_xml":"https://content.openalex.org/works/W2990399187.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1716405613","https://openalex.org/W2109814431","https://openalex.org/W2144677985","https://openalex.org/W2147997050","https://openalex.org/W2413702044","https://openalex.org/W2467264597","https://openalex.org/W2477520558","https://openalex.org/W2489758720","https://openalex.org/W2521010565","https://openalex.org/W2536287248","https://openalex.org/W2547589532","https://openalex.org/W2560653497","https://openalex.org/W2560804544","https://openalex.org/W2562457628","https://openalex.org/W2565718891","https://openalex.org/W2570990198","https://openalex.org/W2582027179","https://openalex.org/W2727879335","https://openalex.org/W2736416755","https://openalex.org/W2749642217","https://openalex.org/W2767781708","https://openalex.org/W2772135503","https://openalex.org/W2782314309","https://openalex.org/W2790911203","https://openalex.org/W2801591369","https://openalex.org/W2884352172","https://openalex.org/W2891364167","https://openalex.org/W2964683145"],"related_works":["https://openalex.org/W4404460088","https://openalex.org/W2970735870","https://openalex.org/W2891364167","https://openalex.org/W3198916239","https://openalex.org/W4392914298","https://openalex.org/W2790911203","https://openalex.org/W7147198145","https://openalex.org/W2912455499","https://openalex.org/W2801591369","https://openalex.org/W3087763370"],"abstract_inverted_index":{"Rezafungin":[0,17],"acetate":[1],"is":[2,18],"a":[3,21,27,84],"novel":[4],"echinocandin":[5],"in":[6,54,60,98],"clinical":[7],"development":[8],"for":[9],"prevention":[10],"and":[11,41,78,93],"treatment":[12,62,100],"of":[13,53,63,67,87,96,101],"invasive":[14,102],"fungal":[15,103],"infections.":[16,104],"differentiated":[19],"by":[20,73],"pharmacokinetic/pharmacodynamic":[22],"(PK/PD)":[23],"profile":[24],"that":[25],"includes":[26],"long":[28],"half\u2010life":[29],"allowing":[30],"once\u2010weekly":[31],"administration,":[32],"front\u2010loaded":[33],"plasma":[34],"drug":[35],"exposures":[36],"associated":[37],"with":[38],"antifungal":[39,91],"efficacy,":[40],"penetration":[42],"into":[43],"deep\u2010seated":[44],"infections,":[45],"such":[46],"as":[47],"intra\u2010abdominal":[48],"abscesses.":[49],"In":[50],"this":[51],"series":[52],"vivo":[55],"studies,":[56],"rezafungin":[57,97],"demonstrated":[58],"efficacy":[59,92],"the":[61,90,99],"neutropenic":[64],"mouse":[65],"models":[66],"disseminated":[68],"candidiasis,":[69],"including":[70],"infection":[71],"caused":[72],"azole\u2010resistant":[74],"Candida":[75],"albicans":[76],",":[77],"aspergillosis.":[79],"These":[80],"results":[81],"contribute":[82],"to":[83],"growing":[85],"body":[86],"evidence":[88],"demonstrating":[89],"potential":[94],"utility":[95]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2990399187","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-12-05T00:00:00"}
